PT  - JOURNAL ARTICLE
AU  - Pontus Andell
AU  - Sasha Koul
AU  - Andreas Martinsson
AU  - Johan Sundström
AU  - Tomas Jernberg
AU  - J Gustav Smith
AU  - Stefan James
AU  - Bertil Lindahl
AU  - David Erlinge
TI  - Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction
AID  - 10.1136/openhrt-2013-000002
DP  - 2014 Feb 01
TA  - Open Heart
PG  - e000002
VI  - 1
IP  - 1
4099  - http://openheart.bmj.com/content/1/1/e000002.short
4100  - http://openheart.bmj.com/content/1/1/e000002.full
SO  - Open Heart2014 Feb 01; 1
AB  - Aim To gain a better understanding of the impact of chronic obstructive pulmonary disease (COPD) on long-term mortality in patients with myocardial infarction (MI) and identify areas where the clinical care for these patients may be improved. Methods Patients hospitalised for MI between 2005 and 2010 were identified from the nationwide Swedish SWEDEHEART registry. Patients with MI and a prior COPD hospital discharge diagnosis were compared to patients with MI without a prior COPD hospital discharge diagnosis for the primary endpoint of all-cause mortality at 1 year after MI. Secondary endpoints included rates of reinfarction, new-onset stroke, new-onset bleeding and new-onset heart failure at 1 year. Results A total of 81 191 MI patients were included, of which 4867 (6%) had a COPD hospital discharge diagnosis at baseline. Patients with COPD showed a significantly higher unadjusted 1-year mortality (24.6 vs 13.8%) as well as a higher rate of reinfarction, new-onset bleeding and new-onset heart failure post-MI. After adjustment for potential confounders, including comorbidities and treatment, the patients with COPD still showed a significantly higher 1-year mortality (HR 1.14, 95% CI 1.07 to 1.21) as well as a higher rate of new-onset heart failure (HR 1.35, 95% CI 1.24 to 1.47), whereas no significant association between COPD and myocardial reinfarction or new-onset bleeding remained. Conclusions In this nationwide contemporary study, patients with COPD frequently had an atypical presentation, less often underwent revascularisation and less often received guideline-recommended secondary preventive medications of established benefit. Prior COPD was associated with a higher 1-year mortality and a higher risk of subsequent new-onset heart failure after MI. The association seems to be mainly explained by differences in background characteristics, comorbidities and treatment, although a minor part might be explained by COPD in itself. Improved in-hospital MI treatment and post-MI secondary prevention according to the guidelines may lower the mortality in this high-risk population.